← Back to Search

Behavioral Intervention

Intervention 1 - Intersectionality and Identity for Sexual and Gender Minorities

N/A
Recruiting
Led By Ana Radovic, MD, MSc
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

"This trial will use different technology tools like YouTube videos, online resources, TikTok videos, and other media to see if they help Sexual and Gender Minority Youth seek mental health help. The participants will be

Who is the study for?
This trial is for Sexual and Gender Minority Youth (SGMY) aged 14-19 who have mild or more severe symptoms of depression and/or anxiety. Participants must be able to use the internet, have finished at least 6th grade, and own a smartphone. The study aims for diversity: half should be sexual minorities but cisgender, half not cisgender, with at least 40% being racial or ethnic minorities.Check my eligibility
What is being tested?
The study tests four online tools designed to encourage SGMY to seek mental health help. These include educational videos and resources on topics like intersectionality and finding supportive caregivers. Participants will use Discord anonymously in groups with varying access to these tools over four weeks, with surveys conducted before and after.See study design
What are the potential side effects?
Since this trial involves non-medical interventions such as educational content and community support through digital media, there are no direct physical side effects expected from participation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the intervention Principle
Feasibility - IP use days
Feasibility - IP use proportion
+3 more
Secondary outcome measures
12 Item Short Form Survay from the RAND Medical Outcomes Study (SF-12)
Antidepressant Outcome Expectations
Anxiety
+13 more

Trial Design

16Treatment groups
Experimental Treatment
Active Control
Group I: Interventions 3 and 4 - Educational Tools/Finding Affirming CareExperimental Treatment3 Interventions
Arm 15 will be given access to interventions 3 and 4. Video and text content will focus on educational tools about identity and determining if caregivers are affirming.
Group II: Interventions 2, 3 and 4 - Confidentiality and Privacy/Educational Tools/Finding Affirming CareExperimental Treatment3 Interventions
Arm 12 will be given access to interventions 2, 3, and 4. Video and text content will focus on confidentiality, education about identity, and determine if caregivers are affirming.
Group III: Interventions 2 and 4 - Confidentiality and Privacy/Finding Affirming CareExperimental Treatment3 Interventions
Arm 13 will be given access to interventions 1, 3, and 4. Video and text content will focus on confidentiality and determining if caregivers are affirming.
Group IV: Interventions 2 and 3 - Confidentiality and Privacy/Educational ToolsExperimental Treatment3 Interventions
Arm 11 will be given access to interventions 2, and 3. Video and text content will focus on confidentiality and education about identity.
Group V: Interventions 1, 3, and 4 - Intersectionality and Identity/Educational Tools/Finding Affirming CareExperimental Treatment2 Interventions
Arm 8 will be given access to interventions 1, 3, and 4, with the video and text content focused on intersectionality, education about identity and determining if caregivers are affirming.
Group VI: Interventions 1, 2, and 4 - Intersectionality/Confidentiality/Finding Affirming CareExperimental Treatment1 Intervention
Arm 5 will be given access to interventions 1, 2, and 4, with the video and text content focused on intersectionality, confidentiality, and determining if caregivers are affirming
Group VII: Interventions 1, 2, and 3 - Intersectionality/Confidentiality/Educational ToolsExperimental Treatment1 Intervention
Arm 4 will be given access to with the video and text content focused on intersectionality, confidentiality, and education about identity
Group VIII: Interventions 1, 2, 3 and 4 - Intersectionality/Confidentiality/Educational Tools/Affirming CareExperimental Treatment2 Interventions
Arm 6 will be given access to all 4 interventions, with the video and text content focused on intersectionality, confidentiality, education about identity, and determining if caregivers are affirming
Group IX: Interventions 1 and 4 - Intersectionality and Identity/Finding Affirming CareExperimental Treatment2 Interventions
Arm 9 will be given access to interventions 1 and 4, with the video and text content focused on intersectionality and determining if caregivers are affirming.
Group X: Interventions 1 and 3 - Intersectionality and Identity/Educational ToolsExperimental Treatment2 Interventions
Arm 7 will be given access to interventions 1 and 3, with the video and text content focused on intersectionality and education about identity
Group XI: Interventions 1 and 2 - Intersectionality and Identity/Confidentiality and PrivacyExperimental Treatment1 Intervention
Arm 3 will be given access to with the video and text content focused on intersectionality and confidentiality
Group XII: Intervention 4 - Finding Affirming CareExperimental Treatment4 Interventions
Arm 16 will be given access to intervention 4, with video and text content focusing on determining if caregivers are affirming.
Group XIII: Intervention 3 - Educational ToolsExperimental Treatment3 Interventions
Arm 14 will be given access to intervention 3. Video and text content will focus on education about identity
Group XIV: Intervention 2 - Confidentiality and PrivacyExperimental Treatment2 Interventions
Arm 10 will be given access to intervention 2, with the video and text content focused on confidentiality
Group XV: Intervention 1 - Intersectionality and IdentityExperimental Treatment1 Intervention
Arm 2 will be given access to intervention 1. It will have video and text content focused on identity and intersectionality.
Group XVI: Control Group - No InterventionsActive Control1 Intervention
Arm 1 will have not be given any of the interventions and will be a control group.

Find a Location

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,263 Total Patients Enrolled
University of PittsburghLead Sponsor
1,723 Previous Clinical Trials
16,342,860 Total Patients Enrolled
Ana Radovic, MD, MScPrincipal InvestigatorUniversity of Pittsburgh/UPMC
2 Previous Clinical Trials
490 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there ongoing efforts to actively enroll participants for this medical study?

"Yes, the details on clinicaltrials.gov suggest that this investigation is presently enlisting participants. Originally listed on March 1st, 2024 and most recently revised on March 22nd, 2024, the trial aims to recruit a total of 96 patients from one designated site."

Answered by AI

Is there an upper age limit for participants being considered in this medical study?

"For eligibility in this study, participants must be at least 14 years old but no older than 19."

Answered by AI

How many individuals in total are enrolled in this research project?

"Affirmative. The information available on clinicaltrials.gov indicates that this particular medical research study is actively seeking eligible individuals. This trial was initially posted on the 1st of March, 2024 and underwent its latest revision on the 22nd of March, 2024. The investigation aims to recruit a total of 96 participants from one designated site."

Answered by AI

What are the specific objectives of this research study?

"The main focus of this clinical investigation, to be assessed over approximately one month, is the acceptance level towards the experimental approach. Additional objectives encompass concerns related to confidentiality, as measured by a specific item within the BASH-B scale where scores range from 1 to 6 indicating degree of agreement regarding therapist's ability to maintain confidentiality. Another secondary goal involves evaluating participants' knowledge about depression and anxiety through an adapted Depression and Anxiety literacy questionnaire (Gulliver 2012) with total scores ranging from 0 to 22 reflecting depth of understanding on these conditions. Furthermore, willingness to seek assistance from various outlets will also be explored using the General"

Answered by AI
~48 spots leftby Jun 2024